SFX by Ex Libris Inc.

Title:	Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts
Source:	Gene Therapy [0969-7128] Régulier, E yr:1998

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Urish, K. "Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration." Current topics in developmental biology 68 (2005): 263-80.
description	2.	Guttinger, M. "Seizure suppression and lack of adenosine A(1) receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts." Experimental Neurology 193.1 (2005): 53-64.
description	3.	Aebischer, P. "Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia." Kidney International 62.4 (2002): 1395-1401.
description	4.	Orive, G. "Bioactive cell-hydrogel microcapsules for cell-based drug delivery." Journal of Controlled Release 135.3 (2009): 203-210.
description	5.	Hedfors, Ida Aagård A. "Retrovirus mediated gene transduction of human T-cell subsets." Cancer immunology, immunotherapy 54.8: 759-768.
description	6.	Goren, A. "Alginate Encapsulated Cells Secreting Fas-Ligand Reduce Lymphoma Carcinogenicity." Cancer science (2011): 116-24.
description	7.	Templeton, Nancy Smyth S. "Optimization of gene expression in nonactivated circulating lymphocytes." Molecular therapy 8.4 (2003): 629-36.
description	8.	Wetherington, Jonathon P P. "Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors." The journal of neuroscience 22.4 (2002): 1248-55.
description	9.	Wang, Y. "Expression of human calcitonin by microencapsulated recombinant myoblasts." Biotechnology letters 28.18 (2006): 1453-8.
description	10.	Shindo, A. "Seizure Suppression in Amygdala-Kindled Mice by Transplantation of Neural Stem/Progenitor Cells Derived From Mouse Embryonic Stem Cells." NEUROLOGIA MEDICO-CHIRURGICA 50.2 (2010): 98-105.
description	11.	Yilmaz, O. "Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis." European journal of neurology 11.8 (2004): 541-4.
description	12.	Fan, P. "The Transcriptome in Blood: Challenges and Solutions for Robust Expression Profiling." Current molecular medicine 5.1 (2005): 3-10.
description	13.	Nath, K A A. "Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1." Kidney international 59.1 (2001): 106-17.
description	14.	Lavasani, M. "Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle." Human gene therapy 17.2 (2006): 180-192.
description	15.	Brüstle, Jing Q Q. "Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants." Brain 130.5 (2007): 1276-88.
description	16.	Nguyen, Kytai T T. "Islet encapsulation: strategies to enhance islet cell functions." Tissue engineering 13.3 (2007): 589-99.
description	17.	Tonnesen, H. "Alginate in drug delivery systems." Drug development and industrial pharmacy 28.6 (2002): 621-630.
description	18.	Mouly, V. "Myoblast transfer therapy: is there any light at the end of the tunnel?" ACTA MYOLOGICA MYOPATHIES AND CARDIOMYOPATHIES 24.2 (2005): 128-33.
description	19.	Herzog, Roland W W. "Systemic protein delivery by muscle-gene transfer is limited by a local immune response." Blood 105.11 (2005): 4226-34.
description	20.	Kiel, David P. "Genetics of the Musculoskeletal System: A Pleiotropic Approach." Journal of bone and mineral research 23.6 (2008): 788-802.